Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)

Phase Distribution

Ph phase_4
1
33%
Ph not_applicable
2
67%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(3)

Detailed Status

Completed3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (33.3%)
N/A2 (66.7%)

Trials by Status

completed3100%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

PGT-A Versus Blastocyst Morphology Selection

NCT03095053
completednot_applicable

Next Generation Sequencing Screening for Embryonic Ploidy Status

NCT02032264
completedphase_4

Sequential vs. Monophasic Media Impact Trial (SuMMIT)

NCT01917240

Clinical Trials (3)

Showing 3 of 3 trials
NCT03095053Not Applicable

PGT-A Versus Blastocyst Morphology Selection

Completed
NCT02032264Not Applicable

Next Generation Sequencing Screening for Embryonic Ploidy Status

Completed
NCT01917240Phase 4

Sequential vs. Monophasic Media Impact Trial (SuMMIT)

Completed

All 3 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
3